• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们是否应该个体化乳腺癌筛查?

Should we individualize breast cancer screening?

机构信息

Department of Senology, CHU of Liège, avenue de l'hôpital B35, Liège, Belgium.

出版信息

Maturitas. 2012 Nov;73(3):202-5. doi: 10.1016/j.maturitas.2012.08.004. Epub 2012 Sep 14.

DOI:10.1016/j.maturitas.2012.08.004
PMID:22981888
Abstract

Publicly organized population breast cancer screening is presently hotly debated. Indeed, population screening is poorly effective, induces harms in a healthy population and is costly. However, stopping all kind of screening of low- and average-risk women would be problematic as about 70% of breast cancers are diagnosed in those subgroups, and maintaining current population screening in high-risk women would be insufficient. We propose herein a review about the advantages and the inconvenience of individualized screening. The latter could be a more efficient strategy. The principles of individualized screening are (a) to start from the age at which the breast cancer risk is equal to that for an average women aged 50 years, (b) to stop when the risk of co-mortality exceeds the risk of breast cancer mortality, (c) to adapt the exams frequency and the imaging modalities to the individual risk and to the breast density, (d) to reassess regularly and individually the screening strategy, and (e) to discuss honestly with each woman in order to help her to decide if she participates or not.

摘要

目前,公众组织的人群乳腺癌筛查备受争议。事实上,人群筛查效果不佳,会对健康人群造成伤害,且费用高昂。然而,停止对低危和中危女性的所有类型筛查可能会产生问题,因为约 70%的乳腺癌发生在这些亚组中,而维持高危女性的现行人群筛查也将是不够的。本文综述了个体化筛查的优势和不便之处。后者可能是一种更有效的策略。个体化筛查的原则包括:(a)从乳腺癌风险等同于 50 岁普通女性的年龄开始筛查;(b)当共存死亡率风险超过乳腺癌死亡率风险时停止筛查;(c)根据个体风险和乳房密度调整检查频率和影像学方式;(d)定期对筛查策略进行个体化重新评估;(e)与每位女性进行坦诚讨论,以帮助她决定是否参与筛查。

相似文献

1
Should we individualize breast cancer screening?我们是否应该个体化乳腺癌筛查?
Maturitas. 2012 Nov;73(3):202-5. doi: 10.1016/j.maturitas.2012.08.004. Epub 2012 Sep 14.
2
Screening and diagnosis of breast cancer in low-resource countries: what is state of the art?资源匮乏国家的乳腺癌筛查与诊断:当前的技术水平如何?
Semin Ultrasound CT MR. 2011 Aug;32(4):300-5. doi: 10.1053/j.sult.2011.04.002.
3
[Using medical imaging for a comprehensive breast cancer screening program].[将医学成像用于全面乳腺癌筛查计划]
Bull Cancer. 2009 Nov;96(11):1071-86. doi: 10.1684/bdc.2009.0976.
4
The use of breast imaging to screen women at high risk for cancer.利用乳腺成像技术对癌症高危女性进行筛查。
Radiol Clin North Am. 2010 Sep;48(5):859-78. doi: 10.1016/j.rcl.2010.06.012.
5
Screening of women at high risk for breast cancer.高危女性乳腺癌筛查。
Prev Med. 2011 Sep;53(3):127-30. doi: 10.1016/j.ypmed.2011.06.017. Epub 2011 Jul 1.
6
Breast cancer screening in women: An integrative literature review.女性乳腺癌筛查:一项综合文献综述。
J Am Acad Nurse Pract. 2010 Dec;22(12):668-73. doi: 10.1111/j.1745-7599.2010.00564.x. Epub 2010 Nov 5.
7
[Population-based breast cancer screening is not worthwhile. Screening has little effect on mortality].基于人群的乳腺癌筛查并不值得。筛查对死亡率几乎没有影响。
Ned Tijdschr Geneeskd. 2011;155(35):A3774.
8
The role of magnetic resonance imaging in screening women at high risk of breast cancer.磁共振成像在乳腺癌高危女性筛查中的作用。
Top Magn Reson Imaging. 2008 Jun;19(3):163-9. doi: 10.1097/RMR.0b013e31818bc994.
9
[Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].[基于个体风险评估对不符合国家人群筛查计划的女性进行乳腺癌筛查]
Ned Tijdschr Geneeskd. 2001 Jan 20;145(3):120-5.
10
Potential impact of USPSTF recommendations on early diagnosis of breast cancer.USPSTF 建议对乳腺癌早期诊断的潜在影响。
Ann Surg Oncol. 2011 Oct;18(11):3137-42. doi: 10.1245/s10434-011-1915-9. Epub 2011 Sep 27.

引用本文的文献

1
Associated morbidity in screened and diagnosed breast cancer patients: a retrospective study.筛查和诊断乳腺癌患者的相关发病情况:一项回顾性研究。
Arch Gynecol Obstet. 2023 May;307(5):1539-1546. doi: 10.1007/s00404-022-06630-0. Epub 2022 Aug 5.
2
Number of prior negative screening outcomes does not influence future risk of breast cancer.先前阴性筛查结果的数量并不影响未来乳腺癌的风险。
Eur J Epidemiol. 2020 Jun;35(6):549-556. doi: 10.1007/s10654-020-00645-0. Epub 2020 May 19.
3
The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
加利福尼亚州乳房密度通知立法对乳腺癌筛查的影响。
J Prim Care Community Health. 2017 Apr;8(2):55-62. doi: 10.1177/2150131916674889. Epub 2016 Oct 31.
4
Breast cancer screening in Albania during 2007-2008.2007 - 2008年阿尔巴尼亚的乳腺癌筛查
Mater Sociomed. 2013 Dec;25(4):270-2. doi: 10.5455/msm.2013.25.270-272. Epub 2013 Nov 24.